From: The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review
Scaffold type | No. of studies | References |
---|---|---|
No Scaffold | 19 (17%) | [49, 54, 61, 70, 72–75, 81, 86, 89–91, 97, 100, 102, 280–282, 284] |
Poly (lactide-co-glycoside) PLGA | 17 (16%) | [56, 59, 62, 63, 83, 88, 150, 153, 160, 277, 285, 286, 289–292, 316] |
Fibrin/Fribrin glue | 11 (9%) | |
Hydrogel | 9 (8%) | |
Collagen | 9 (8%) | |
Hyaluronic acid | 7 (6%) | |
Alginate beads | 4 (3%) | |
Tissue membrane | 4 (3%) | |
Polyglycolic acid | 3 (3%) | |
PGA/PLA | 3 (3%) | |
Hylauronan crosslinked matrix | 2 (2%) | |
Poly-L-lactide-co-caprolactone | 2 (2%) | |
Polycaprolactone cartilage (PCL) | 2 (2%) | |
Animal-origin osteochondral plug scaffold | 2 (2%) | |
Chitosan microspheres and fibrin glue | 1 (<1%) | [60] |
Gel carries (collagen/HA/Fibrogen) | 1 (<1%) | [71] |
Polychoxanone/poly(vinyl alcholo) PDO/PVA | 1 (<1%) | [302] |
Cartilage aggregate | 1 (<1%) | [306] |
Collagen/glycosaminoglycan porous titanium biphasic scaffold | 1 (<1%) | [151] |
Articular chondrocyte seeded matrix associated autologous chondrocyte transplant (MACT) | 1 (<1%) | [313] |
MSC-ADM (accellulo-dermal matrix) | 1 (<1%) | [319] |
Hyaff-11 scaffold | 1 (<1%) | [295] |
Porous-gelatin-chonroitin hyaluronate | 1 (<1%) | [291] |
Bone protein 7 PCL | 1 (<1%) | [66] |
Human acellular amniotic membrane | 1 (<1%) | [307] |
Pluronic-F 127 | 1 (<1%) | [102] |
Tricalcium phosphate | 1 (<1%) | [315] |
Agarose | 1 (<1%) | [311] |
GCH-GCBB | 1 (<1%) | [93] |
ACHMS (atelocollagen honeycomb-shaped membrane) | 1 (<1%) | [58] |
Magnet | 1 (<1%) | [310] |
Human cartilage extra cellular matrix 3D porous acellular | 1 (<1%) | [67] |